Translation of the instructions can be
ALTEIKA chewable tablets 0.12 g
Instruction
For medical use of the medicinal product
Altai
Composition:
Active ingredient: 1 tablet contains dry marshmallow root extract (althaeae radix extractum siccum) (4: 1) - 0.12 g;
Excipients: magnesium carbonate, lactose, aspartame (E 951), povidone, orange flavoring, magnesium stearate.
Dosage form.
Chewable tablets.
Main physicochemical properties: tablets of grayish-brown color with inclusions, with a flat surface, a score and a bevel.
Pharmacotherapeutic group.
Remedies used for coughs and colds. Expectorants. Marshmallow roots.
PBX code R05C A05.
Pharmacological properties.
Pharmacodynamics.
Direct-acting expectorant. A herbal preparation containing dry extract of marshmallow root, the main biologically active substances of which are polysaccharides, as well as pectins, amino acids, starch. The polysaccharides of the preparation are absorbed into the blood, partially secreted by the bronchial glands and have an enveloping, softening and anti-inflammatory effect on the mucous membrane of the upper respiratory tract, somewhat increasing the secretion of the liquid component of the bronchial secretion and normalizing its rheological properties (viscosity, elasticity, adhesiveness). Strengthens the peristaltic movements of the bronchioles and the motor function of the ciliated epithelium of the bronchi, contributing to the excretion of sputum.
Pharmacokinetics.
Didn't study.
Clinical characteristics.
Indication.
As part of the complex treatment of acute and chronic inflammatory diseases of the respiratory system: laryngitis, tracheitis, bronchitis, bronchial asthma, whooping cough.
Contraindication.
Hypersensitivity to the components of the drug, diabetes mellitus.
Interaction with other drugs and other types of interactions.
It is not recommended to use simultaneously with antitussives (codeine).
Application features.
It should not be administered to patients with rare hereditary diseases such as fructose intolerance, glucose-galactose malabsorption syndrome or sucrose-isomaltose insufficiency.
Given the aspartame content in the composition, it cannot be used by patients with phenylketonuria.
Use during pregnancy or breastfeeding.
There is no experience with the use of the drug during pregnancy and breastfeeding.
The ability to influence the reaction speed when driving vehicles or other mechanisms.
No effect.
Method of administration and doses.
For oral use. Take before meals, chew and drink with a small amount of water.
Adults and children over 14 years of age should be prescribed 1 tablet 4-6 times a day.
Doses for children, depending on age, are:
7-14 years old - 1 tablet 3-4 times a day;
2-7 years - ½ tablet 3-4 times a day.
The duration of treatment is determined by the doctor individually, usually from 7 days to 2 weeks.
Children.
Use in children aged 2 years and over.
Overdose.
Cases of drug overdose have not been described.
Adverse reactions.
In some cases, allergic reactions are possible, including urticaria, itching. If any adverse reactions occur, treatment should be discontinued and a doctor should be consulted.
Expiration date.
2 years.
Storage conditions.
Store in a dry place at a temperature not exceeding 25 ºC.
Keep out of reach of children.
Packaging.
No. 20 (10 × 2), No. 50 (10 × 5) in a blister in a pack.
Vacation category.
Without a prescription.
Manufacturer/applicant.
"Ternofarm" LLC.
Location of the manufacturer and address of its place of business.
"Ternofarm" LLC.
Ukraine, 46010, Ternopil, Fabrychna St., 4.
ALTEIKA-TERNOPHARM syrup
Instruction
For medical use of the medicinal product
Alteika-Ternofarm
composition:
Active ingredient: Marshmallow root dry extract (4:1);
5 ml of syrup contain dry marshmallow root extract (Althaeae radix extractum siccum) (4: 1) (extractant - water) in terms of polysaccharides 7.5 mg;
excipients: sodium methylparaben (E 219), sodium propylparaben (E 217), citric acid, confectioner's sugar, purified water.
Dosage form.
Syrup.
Main physicochemical properties: syrupy liquid from light brown to red-brown in color with a specific odor. During storage, precipitation is allowed.
Pharmacotherapeutic group.
Remedies used for coughs and colds. Expectorants. Marshmallow roots.
PBX code R05C A05.
Pharmacological properties.
Pharmacodynamics.
Direct-acting expectorant. A herbal preparation, the main active ingredients of which are polysaccharides, as well as pectins, amino acids, starch, etc. The polysaccharides of the preparation are absorbed into the blood, partially secreted by the bronchial glands and have an enveloping, softening and anti-inflammatory effect on the mucous membrane of the upper respiratory tract, to a certain extent increasing the secretion of the liquid component of the bronchial secretion and normalizing its rheological properties (viscosity, elasticity, adhesiveness). Strengthens the peristaltic movements of the bronchioles and the motor function of the ciliated epithelium of the bronchi, contributing to the excretion of sputum.
Pharmacokinetics.
Didn't study.
Clinical characteristics.
Indication.
Contraindication.
Hypersensitivity to the components of the drug.
Interaction with other drugs and other types of interactions.
It is not recommended to use simultaneously with antitussives (e.g. codeine).
Application features.
Use during pregnancy or breastfeeding.
The drug is not used because there is no information on the experience of using the drug during pregnancy and breastfeeding.
The ability to influence the reaction speed when driving vehicles or other mechanisms.
The use of the drug usually does not affect the reaction speed when driving vehicles or other mechanisms.
Method of administration and doses.
The drug is taken before meals.
Adults and children over 14 years old - 15 ml of syrup 4-6 times a day.
Children 6-14 years old - 10 ml of syrup 4-6 times a day.
Children 2-6 years old - 5 ml of syrup 4-6 times a day.
For children aged 2 to 6 years, a certain dose of syrup is diluted in the required amount of boiled water (10-15 ml).
The duration of the treatment course is determined by the doctor individually depending on the effectiveness of the therapy and is usually 7-14 days.
Children.
The drug is used in children from 2 years of age.
Overdose.
Cases of drug overdose have not been described.
Adverse reactions.
Allergic reactions, increased salivation, irritation of the gastric mucosa are possible. In case of any adverse reactions, treatment with the drug should be discontinued and consult a doctor.
Expiration date.
2 years.
Storage conditions.
Store in the original packaging at a temperature not exceeding 25 °C.
After opening, store for no more than 14 days at a temperature not exceeding 25 °C.
Keep out of reach of children.
Packaging.
100 ml or 200 ml in a bottle; 1 bottle with a measuring spoon or measuring cup in a pack.
Vacation category.
Without a prescription.
Producer.
"Ternofarm" LLC.
Location of production and its address of place of business / location of the applicant.
